A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy

There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart and vessels 2020-08, Vol.35 (8), p.1164-1170
Hauptverfasser: Kageyama, Shigetaka, Mitake, Hirotsugu, Nakajima, Atsuo, Kodama, Keita, Hattori, Yusuke, Watanabe, Yuzo, Sugiyama, Hirofumi, Kawahito, Michitomo, Takeuchi, Ryosuke, Murata, Koichiro, Nawada, Ryuzo, Onodera, Tomoya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1170
container_issue 8
container_start_page 1164
container_title Heart and vessels
container_volume 35
creator Kageyama, Shigetaka
Mitake, Hirotsugu
Nakajima, Atsuo
Kodama, Keita
Hattori, Yusuke
Watanabe, Yuzo
Sugiyama, Hirofumi
Kawahito, Michitomo
Takeuchi, Ryosuke
Murata, Koichiro
Nawada, Ryuzo
Onodera, Tomoya
description There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or > 2 of the following factors: SBP  45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery.
doi_str_mv 10.1007/s00380-020-01583-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2378897893</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2419738766</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</originalsourceid><addsrcrecordid>eNp9kUFvFCEUx4mxsdvqF_BgSLx4GQu8nQGOm0atSRMv7ZmwzKNLnRlGYNrs9_ADy3arJh48EAj_H3_ee39C3nL2kTMmLzJjoFjDRF28VdDAC7LiHW8b0Up4SVZMc9YoEPKUnOV8zyqluX5FTkFw1a51uyI_N3SKDzjQFPJ3ml1MSONEbT-GnEM9-ZjonLAProTpjvZoy47WuwmxfxLzku4w7WmY6GxLwKlk-hgqZN1SkJb9jHRT1ZLsuCQ70B2OtsTR0oQOw8PBdTz4V6nsMNl5_5qceDtkfPO8n5Pbz59uLq-a629fvl5urhsHWpemdbBWwDRzkquthF6KjgEyj4Cyh61F2Xrtte6c5t3a-144r5hGraEVrYBz8uHoO6f4Y8FcTO3a4TDYCeOSjQCplJZKQ0Xf_4PexyVNtToj1lxLULLrKiWOlEsx54TezCmMNu0NZ-aQmTlmZmpm5ikzc7B-92y9bOsg_jz5HVIF4AjkKk112H___o_tL_BFo0M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419738766</pqid></control><display><type>article</type><title>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Kageyama, Shigetaka ; Mitake, Hirotsugu ; Nakajima, Atsuo ; Kodama, Keita ; Hattori, Yusuke ; Watanabe, Yuzo ; Sugiyama, Hirofumi ; Kawahito, Michitomo ; Takeuchi, Ryosuke ; Murata, Koichiro ; Nawada, Ryuzo ; Onodera, Tomoya</creator><creatorcontrib>Kageyama, Shigetaka ; Mitake, Hirotsugu ; Nakajima, Atsuo ; Kodama, Keita ; Hattori, Yusuke ; Watanabe, Yuzo ; Sugiyama, Hirofumi ; Kawahito, Michitomo ; Takeuchi, Ryosuke ; Murata, Koichiro ; Nawada, Ryuzo ; Onodera, Tomoya</creatorcontrib><description>There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or &gt; 2 of the following factors: SBP &lt; 120 mmHg, ascending aorta diameter &gt; 45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery.</description><identifier>ISSN: 0910-8327</identifier><identifier>EISSN: 1615-2573</identifier><identifier>DOI: 10.1007/s00380-020-01583-3</identifier><identifier>PMID: 32185495</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Aged ; Aged, 80 and over ; Aorta ; Aortic Diseases - diagnostic imaging ; Aortic Diseases - mortality ; Aortic Diseases - therapy ; Aortic dissection ; Biomedical Engineering and Bioengineering ; Blood pressure ; Cardiac Surgery ; Cardiology ; Clinical Decision Rules ; Clinical Decision-Making ; Computed tomography ; Conservative Treatment - adverse effects ; Conservative Treatment - mortality ; Coronary vessels ; Death ; Effusion ; Emergency Service, Hospital ; Female ; Forecasting ; Health services ; Hematoma ; Hematoma - diagnostic imaging ; Hematoma - mortality ; Hematoma - therapy ; Humans ; Japan ; Male ; Medical treatment ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Mortality ; Multivariate analysis ; Original Article ; Patient Admission ; Patients ; Predictive Value of Tests ; Retrospective Studies ; Risk analysis ; Risk Assessment ; Risk Factors ; Risk groups ; Sensitivity analysis ; Surgery ; Treatment Outcome ; Vascular Surgery ; Vascular Surgical Procedures - adverse effects ; Vascular Surgical Procedures - mortality</subject><ispartof>Heart and vessels, 2020-08, Vol.35 (8), p.1164-1170</ispartof><rights>Springer Japan KK, part of Springer Nature 2020</rights><rights>Springer Japan KK, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</citedby><cites>FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00380-020-01583-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00380-020-01583-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32185495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kageyama, Shigetaka</creatorcontrib><creatorcontrib>Mitake, Hirotsugu</creatorcontrib><creatorcontrib>Nakajima, Atsuo</creatorcontrib><creatorcontrib>Kodama, Keita</creatorcontrib><creatorcontrib>Hattori, Yusuke</creatorcontrib><creatorcontrib>Watanabe, Yuzo</creatorcontrib><creatorcontrib>Sugiyama, Hirofumi</creatorcontrib><creatorcontrib>Kawahito, Michitomo</creatorcontrib><creatorcontrib>Takeuchi, Ryosuke</creatorcontrib><creatorcontrib>Murata, Koichiro</creatorcontrib><creatorcontrib>Nawada, Ryuzo</creatorcontrib><creatorcontrib>Onodera, Tomoya</creatorcontrib><title>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</title><title>Heart and vessels</title><addtitle>Heart Vessels</addtitle><addtitle>Heart Vessels</addtitle><description>There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or &gt; 2 of the following factors: SBP &lt; 120 mmHg, ascending aorta diameter &gt; 45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aorta</subject><subject>Aortic Diseases - diagnostic imaging</subject><subject>Aortic Diseases - mortality</subject><subject>Aortic Diseases - therapy</subject><subject>Aortic dissection</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Blood pressure</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Clinical Decision Rules</subject><subject>Clinical Decision-Making</subject><subject>Computed tomography</subject><subject>Conservative Treatment - adverse effects</subject><subject>Conservative Treatment - mortality</subject><subject>Coronary vessels</subject><subject>Death</subject><subject>Effusion</subject><subject>Emergency Service, Hospital</subject><subject>Female</subject><subject>Forecasting</subject><subject>Health services</subject><subject>Hematoma</subject><subject>Hematoma - diagnostic imaging</subject><subject>Hematoma - mortality</subject><subject>Hematoma - therapy</subject><subject>Humans</subject><subject>Japan</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Original Article</subject><subject>Patient Admission</subject><subject>Patients</subject><subject>Predictive Value of Tests</subject><subject>Retrospective Studies</subject><subject>Risk analysis</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Risk groups</subject><subject>Sensitivity analysis</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><subject>Vascular Surgery</subject><subject>Vascular Surgical Procedures - adverse effects</subject><subject>Vascular Surgical Procedures - mortality</subject><issn>0910-8327</issn><issn>1615-2573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFvFCEUx4mxsdvqF_BgSLx4GQu8nQGOm0atSRMv7ZmwzKNLnRlGYNrs9_ADy3arJh48EAj_H3_ee39C3nL2kTMmLzJjoFjDRF28VdDAC7LiHW8b0Up4SVZMc9YoEPKUnOV8zyqluX5FTkFw1a51uyI_N3SKDzjQFPJ3ml1MSONEbT-GnEM9-ZjonLAProTpjvZoy47WuwmxfxLzku4w7WmY6GxLwKlk-hgqZN1SkJb9jHRT1ZLsuCQ70B2OtsTR0oQOw8PBdTz4V6nsMNl5_5qceDtkfPO8n5Pbz59uLq-a629fvl5urhsHWpemdbBWwDRzkquthF6KjgEyj4Cyh61F2Xrtte6c5t3a-144r5hGraEVrYBz8uHoO6f4Y8FcTO3a4TDYCeOSjQCplJZKQ0Xf_4PexyVNtToj1lxLULLrKiWOlEsx54TezCmMNu0NZ-aQmTlmZmpm5ikzc7B-92y9bOsg_jz5HVIF4AjkKk112H___o_tL_BFo0M</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Kageyama, Shigetaka</creator><creator>Mitake, Hirotsugu</creator><creator>Nakajima, Atsuo</creator><creator>Kodama, Keita</creator><creator>Hattori, Yusuke</creator><creator>Watanabe, Yuzo</creator><creator>Sugiyama, Hirofumi</creator><creator>Kawahito, Michitomo</creator><creator>Takeuchi, Ryosuke</creator><creator>Murata, Koichiro</creator><creator>Nawada, Ryuzo</creator><creator>Onodera, Tomoya</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20200801</creationdate><title>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</title><author>Kageyama, Shigetaka ; Mitake, Hirotsugu ; Nakajima, Atsuo ; Kodama, Keita ; Hattori, Yusuke ; Watanabe, Yuzo ; Sugiyama, Hirofumi ; Kawahito, Michitomo ; Takeuchi, Ryosuke ; Murata, Koichiro ; Nawada, Ryuzo ; Onodera, Tomoya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aorta</topic><topic>Aortic Diseases - diagnostic imaging</topic><topic>Aortic Diseases - mortality</topic><topic>Aortic Diseases - therapy</topic><topic>Aortic dissection</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Blood pressure</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Clinical Decision Rules</topic><topic>Clinical Decision-Making</topic><topic>Computed tomography</topic><topic>Conservative Treatment - adverse effects</topic><topic>Conservative Treatment - mortality</topic><topic>Coronary vessels</topic><topic>Death</topic><topic>Effusion</topic><topic>Emergency Service, Hospital</topic><topic>Female</topic><topic>Forecasting</topic><topic>Health services</topic><topic>Hematoma</topic><topic>Hematoma - diagnostic imaging</topic><topic>Hematoma - mortality</topic><topic>Hematoma - therapy</topic><topic>Humans</topic><topic>Japan</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Original Article</topic><topic>Patient Admission</topic><topic>Patients</topic><topic>Predictive Value of Tests</topic><topic>Retrospective Studies</topic><topic>Risk analysis</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Risk groups</topic><topic>Sensitivity analysis</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><topic>Vascular Surgery</topic><topic>Vascular Surgical Procedures - adverse effects</topic><topic>Vascular Surgical Procedures - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kageyama, Shigetaka</creatorcontrib><creatorcontrib>Mitake, Hirotsugu</creatorcontrib><creatorcontrib>Nakajima, Atsuo</creatorcontrib><creatorcontrib>Kodama, Keita</creatorcontrib><creatorcontrib>Hattori, Yusuke</creatorcontrib><creatorcontrib>Watanabe, Yuzo</creatorcontrib><creatorcontrib>Sugiyama, Hirofumi</creatorcontrib><creatorcontrib>Kawahito, Michitomo</creatorcontrib><creatorcontrib>Takeuchi, Ryosuke</creatorcontrib><creatorcontrib>Murata, Koichiro</creatorcontrib><creatorcontrib>Nawada, Ryuzo</creatorcontrib><creatorcontrib>Onodera, Tomoya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Heart and vessels</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kageyama, Shigetaka</au><au>Mitake, Hirotsugu</au><au>Nakajima, Atsuo</au><au>Kodama, Keita</au><au>Hattori, Yusuke</au><au>Watanabe, Yuzo</au><au>Sugiyama, Hirofumi</au><au>Kawahito, Michitomo</au><au>Takeuchi, Ryosuke</au><au>Murata, Koichiro</au><au>Nawada, Ryuzo</au><au>Onodera, Tomoya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</atitle><jtitle>Heart and vessels</jtitle><stitle>Heart Vessels</stitle><addtitle>Heart Vessels</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>35</volume><issue>8</issue><spage>1164</spage><epage>1170</epage><pages>1164-1170</pages><issn>0910-8327</issn><eissn>1615-2573</eissn><abstract>There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or &gt; 2 of the following factors: SBP &lt; 120 mmHg, ascending aorta diameter &gt; 45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>32185495</pmid><doi>10.1007/s00380-020-01583-3</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0910-8327
ispartof Heart and vessels, 2020-08, Vol.35 (8), p.1164-1170
issn 0910-8327
1615-2573
language eng
recordid cdi_proquest_miscellaneous_2378897893
source MEDLINE; SpringerNature Journals
subjects Aged
Aged, 80 and over
Aorta
Aortic Diseases - diagnostic imaging
Aortic Diseases - mortality
Aortic Diseases - therapy
Aortic dissection
Biomedical Engineering and Bioengineering
Blood pressure
Cardiac Surgery
Cardiology
Clinical Decision Rules
Clinical Decision-Making
Computed tomography
Conservative Treatment - adverse effects
Conservative Treatment - mortality
Coronary vessels
Death
Effusion
Emergency Service, Hospital
Female
Forecasting
Health services
Hematoma
Hematoma - diagnostic imaging
Hematoma - mortality
Hematoma - therapy
Humans
Japan
Male
Medical treatment
Medicine
Medicine & Public Health
Middle Aged
Mortality
Multivariate analysis
Original Article
Patient Admission
Patients
Predictive Value of Tests
Retrospective Studies
Risk analysis
Risk Assessment
Risk Factors
Risk groups
Sensitivity analysis
Surgery
Treatment Outcome
Vascular Surgery
Vascular Surgical Procedures - adverse effects
Vascular Surgical Procedures - mortality
title A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A07%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20risk%20score%20on%20admission%20for%20predicting%20death%20or%20need%20for%20surgery%20in%20patients%20with%20acute%20type%20A%20intramural%20hematoma%20receiving%20medical%20therapy&rft.jtitle=Heart%20and%20vessels&rft.au=Kageyama,%20Shigetaka&rft.date=2020-08-01&rft.volume=35&rft.issue=8&rft.spage=1164&rft.epage=1170&rft.pages=1164-1170&rft.issn=0910-8327&rft.eissn=1615-2573&rft_id=info:doi/10.1007/s00380-020-01583-3&rft_dat=%3Cproquest_cross%3E2419738766%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2419738766&rft_id=info:pmid/32185495&rfr_iscdi=true